Linagliptin impurity S

Linagliptin impurity S is a brominated synthetic byproduct arising from the alkylation step during linagliptin synthesis. It features a 4-bromophenyl substituent on the piperazine ring, replacing the native 4-fluorophenyl moiety of the parent drug. This structural modification introduces a bromine atom at the para-position of the aromatic ring, altering electronic and steric properties while retaining the core pyrazine-pyrimidine scaffold. The compound serves as a critical HPLC reference standard for quantifying this specific process-related impurity in linagliptin active pharmaceutical ingredients.